J Kastelein - JoVE Visualize

Showing results (131-140 of 184) with videos related to

Pageof 19

Sort By:

Human Gene Therapy|January 26, 2000

Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transferG Liu, K J Ashbourne Excoffon, J E Wilson, et al.

Genomics|July 1, 1992

A missense mutation (Asp250----Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestriesY Ma, B I Wilson, S Bijvoet, et al.

Pediatric Research|May 1, 1996

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemiaH C Knipscheer, C C Boelen, J J Kastelein, et al.

Journal of Lipid Research|June 4, 1998

Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-IA von Eckardstein, A Chirazi, S Schuler-Lüttmann, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997

Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patientsH Jansen, A J Verhoeven, L Weeks, et al.

The Journal of Biological Chemistry|January 25, 1992

Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysisY H Ma, T Bruin, S Tuzgol, et al.

Journal of Clinical Lipidology|June 16, 2015

Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study)Christie M Ballantyne, Rene A Braeckman, Harold E Bays, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995

Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemiaS N Pimstone, S E Gagné, C Gagné, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999

A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaM E Wittekoek, E Moll, S N Pimstone, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995

Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.

Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:

Pageof 19

Human Gene Therapy|January 26, 2000

Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transferG Liu, K J Ashbourne Excoffon, J E Wilson, et al.

Genomics|July 1, 1992

A missense mutation (Asp250----Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestriesY Ma, B I Wilson, S Bijvoet, et al.

Pediatric Research|May 1, 1996

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemiaH C Knipscheer, C C Boelen, J J Kastelein, et al.

Journal of Lipid Research|June 4, 1998

Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-IA von Eckardstein, A Chirazi, S Schuler-Lüttmann, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997

Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patientsH Jansen, A J Verhoeven, L Weeks, et al.

The Journal of Biological Chemistry|January 25, 1992

Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysisY H Ma, T Bruin, S Tuzgol, et al.

Journal of Clinical Lipidology|June 16, 2015

Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study)Christie M Ballantyne, Rene A Braeckman, Harold E Bays, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995

Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemiaS N Pimstone, S E Gagné, C Gagné, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1999

A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemiaM E Wittekoek, E Moll, S N Pimstone, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995

Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.

Pageof 19